{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:08:20Z","timestamp":1773454100221,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Previous study reported that patients who suffered coronary heart disease (CHD) complicated with non-alcoholic fatty liver disease (NAFLD) had worse cardiac function and clinical outcomes than patients with CHD only. Notably, the mechanism is still unclear. This study aimed to investigate the changes and roles of intestinal bacterial microbiota in CHD-NAFLD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>People were recruited and divided into three groups, including CHD patients (without NAFLD), CHD-NAFLD patients and healthy controls (HCs). Each group contained 24 people. Fecal samples and clinical information were carefully collected. The Illumina sequencing of 16S rRNA was applied to profile the overall structure of the fecal bacterial microbiota and the characteristics of the bacterial microbiota based on the Operational Taxonomic Units. In clinical information, the CHD-NAFLD patients showed an increase in BMI, uric acid and triglyceride. There was a significant reduction in the abundance of<jats:italic>Parabacteroides<\/jats:italic>and<jats:italic>Collinsella<\/jats:italic>in overall CHD patients (including CHD-NAFLD and CHD patients). The intestinal bacterial microbiota in CHD-NAFLD patients showed an increase in the abundance of<jats:italic>Copococcus<\/jats:italic>and<jats:italic>Veillonella<\/jats:italic>, and a reduction in the abundance of<jats:italic>Parabacteroides<\/jats:italic>,<jats:italic>Bacteroides fragilis<\/jats:italic>,<jats:italic>Ruminococcus gnavus, Bacteroides dorei<\/jats:italic>, and<jats:italic>Bifidobacterium longum subsp infantis<\/jats:italic>. Among them, the abundance of<jats:italic>Ruminococcus gnavus<\/jats:italic>and<jats:italic>Bacteroides dorei<\/jats:italic>was significantly lower than that in CHD patients. Additionally, BMI positively correlated with the abundance of<jats:italic>Copococcus<\/jats:italic>and negatively correlated with the abundance of<jats:italic>Bifidobacterium longum subsp infantis<\/jats:italic>. The abundance of<jats:italic>Veillonella<\/jats:italic>positively correlated with AST. The abundance of<jats:italic>Bacteroides dorei<\/jats:italic>negatively correlated with ALT and AST. It indicates that the abundance of intestinal microbiota was related to the changes in clinical indexes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Changes of intestinal bacterial microbiota in CHD-NAFLD patients may be important factors affecting the degree of metabolic disorder, which may be one of the important reasons for the worse clinical outcome and disease progression in CHD-NAFLD patients than in CHD patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12864-019-6251-7","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T16:02:49Z","timestamp":1573747369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Yiwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"10","key":"6251_CR1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","volume":"33","author":"LS Bhatia","year":"2012","unstructured":"Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33(10):1190\u2013200.","journal-title":"Eur Heart J"},{"issue":"10","key":"6251_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","volume":"13","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10):1579\u201384.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"6251_CR3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59(3):1174\u201397.","journal-title":"Hepatology."},{"issue":"5","key":"6251_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology."},{"issue":"12","key":"6251_CR5","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gut.2011.242016","volume":"60","author":"WS Wong","year":"2011","unstructured":"Wong WS, Wong LH, Yip WK, Lo OS, Limquiaco J, Chu CW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60(12):1721.","journal-title":"Gut."},{"issue":"6","key":"6251_CR6","first-page":"376","volume":"36","author":"AT Alper","year":"2008","unstructured":"Alper AT, Hasdemir H, Sahin S, Ont\u00fcrk E, Akyol A, Nurkalem Z, et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2008;36(6):376.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"6251_CR7","doi-asserted-by":"crossref","unstructured":"Sanduzzi Zamparelli M, Compare D, Coccoli P, Rocco A, Nardone OM, Marrone G, et al. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. International journal of molecular sciences. 2016;17(8).","DOI":"10.3390\/ijms17081225"},{"issue":"9","key":"6251_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts AB, Gu X, Buffa JA, Hurd AG, Wang Z, Zhu W, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018;24(9):1407\u201317.","journal-title":"Nat Med"},{"key":"6251_CR9","doi-asserted-by":"crossref","unstructured":"Continuing Medical Education Exam 2: Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study. Gastroenterology. 2011;140:e12.","DOI":"10.1053\/j.gastro.2010.11.018"},{"issue":"6","key":"6251_CR10","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099.","journal-title":"Hepatology."},{"issue":"5","key":"6251_CR11","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346.","journal-title":"Hepatology."},{"key":"6251_CR12","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096.","journal-title":"Sci Rep"},{"issue":"10","key":"6251_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201700942","volume":"62","author":"LR Hoving","year":"2018","unstructured":"Hoving LR, Katiraei S, Heijink M, Pronk A, van der Wee-Pals L, Streefland T, et al. Dietary Mannan oligosaccharides modulate gut microbiota, increase fecal bile acid excretion, and decrease plasma cholesterol and atherosclerosis development. Mol Nutr Food Res. 2018;62(10):e1700942.","journal-title":"Mol Nutr Food Res"},{"issue":"7\u20138","key":"6251_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.nut.2014.01.014","volume":"30","author":"O Guardamagna","year":"2014","unstructured":"Guardamagna O, Amaretti A, Puddu PE, Raimondi S, Abello F, Cagliero P, et al. Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children. Nutrition (Burbank, Los Angeles County, Calif). 2014;30(7\u20138):831\u20136.","journal-title":"Nutrition (Burbank, Los Angeles County, Calif)"},{"issue":"4","key":"6251_CR15","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00204-016-1859-8","volume":"91","author":"O Rom","year":"2017","unstructured":"Rom O, Korach-Rechtman H, Hayek T, Danin-Poleg Y, Bar H, Kashi Y, et al. Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice. Arch Toxicol. 2017;91(4):1709\u201325.","journal-title":"Arch Toxicol"},{"issue":"30","key":"6251_CR16","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1021\/acs.jafc.8b02979","volume":"66","author":"W Li","year":"2018","unstructured":"Li W, Zhang K, Yang H. Pectin alleviates high fat (lard) diet-induced nonalcoholic fatty liver disease in mice: possible role of short-chain fatty acids and gut microbiota regulated by pectin. J Agric Food Chem. 2018;66(30):8015\u201325.","journal-title":"J Agric Food Chem"},{"key":"6251_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.physbeh.2017.02.027","volume":"173","author":"T Sen","year":"2017","unstructured":"Sen T, Cawthon CR, Ihde BT, Hajnal A, DiLorenzo PM, de La Serre CB, et al. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav. 2017;173:305\u201317.","journal-title":"Physiol Behav"},{"key":"6251_CR18","doi-asserted-by":"crossref","unstructured":"Parks DH, Tyson GW, Philip H, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics (Oxford, England). 2014;30(21):\u20133123.","DOI":"10.1093\/bioinformatics\/btu494"},{"issue":"24","key":"6251_CR19","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia Muciniphila protects against atherosclerosis by preventing metabolic Endotoxemia-induced inflammation in Apoe\u2212\/\u2212 mice. Circulation. 2016;133(24):2434\u201346.","journal-title":"Circulation."},{"key":"6251_CR20","doi-asserted-by":"crossref","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nature Communications. 2017;8(1).","DOI":"10.1038\/s41467-017-00900-1"},{"issue":"1","key":"6251_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-018-0441-4","volume":"6","author":"X Zhou","year":"2018","unstructured":"Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6(1):66.","journal-title":"Microbiome."},{"issue":"7415","key":"6251_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Rob K. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330.","journal-title":"Nature."},{"key":"6251_CR23","doi-asserted-by":"crossref","unstructured":"Shade A. Diversity is the question, not the answer. The ISME journal 2017;11(1):1\u20136.","DOI":"10.1038\/ismej.2016.118"},{"issue":"6","key":"6251_CR24","doi-asserted-by":"publisher","first-page":"6ra14","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14.","journal-title":"Sci Transl Med"},{"key":"6251_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","volume":"66","author":"B Ma","year":"2012","unstructured":"Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371\u201389.","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"6251_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ncomms2266","volume":"3","author":"FH Karlsson","year":"2012","unstructured":"Karlsson FH, F\u00e5k F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3(4):1245.","journal-title":"Nat Commun"},{"key":"6251_CR27","doi-asserted-by":"crossref","unstructured":"Gomezarango LF, Barrett HL, Wilkinson SA, Callaway LK, Mcintyre HD, Morrison M, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2017:00-.","DOI":"10.1080\/19490976.2017.1406584"},{"issue":"2","key":"6251_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/omi.2017.0130","volume":"22","author":"TJ Khan","year":"2018","unstructured":"Khan TJ, Ahmed YM, Zamzami MA, Siddiqui AM, Khan I, Baothman OAS, et al. Atorvastatin treatment modulates the gut microbiota of the Hypercholesterolemic patients. Omics : a journal of integrative biology. 2018;22(2):154\u201363.","journal-title":"Omics : a journal of integrative biology"},{"key":"6251_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fmicb.2017.01687","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu Z, Liu HY, Zhou H, Zhan Q, Lai W, Zeng Q, et al. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 2017;8:1687.","journal-title":"Front Microbiol"},{"issue":"Pt 7","key":"6251_CR30","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1099\/mic.0.27712-0","volume":"151","author":"D Beaud","year":"2005","unstructured":"Beaud D, Tailliez P, Anba-Mondoloni J. Genetic characterization of the beta-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus. Microbiology (Reading, England). 2005;151(Pt 7):2323\u201330.","journal-title":"Microbiology (Reading, England)"},{"issue":"7","key":"6251_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200305","volume":"13","author":"MF Zacarias","year":"2018","unstructured":"Zacarias MF, Collado MC, Gomez-Gallego C, Flinck H, Aittoniemi J, Isolauri E, et al. Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester. PLoS One. 2018;13(7):e0200305.","journal-title":"PLoS One"},{"key":"6251_CR32","doi-asserted-by":"crossref","unstructured":"Ottman N, Huuskonen L, Reunanen J, Boeren S, Klievink J, Smidt H, et al. Characterization of Outer Membrane Proteome ofAkkermansia muciniphilaReveals Sets of Novel Proteins Exposed to the Human Intestine. Frontiers in Microbiology. 2016;7(58).","DOI":"10.3389\/fmicb.2016.01157"},{"issue":"22","key":"6251_CR33","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138(22):2486\u201398.","journal-title":"Circulation."},{"key":"6251_CR34","doi-asserted-by":"crossref","unstructured":"Yoshida N, Sasaki K, Sasaki D, Yamashita T, Fukuda H, Hayashi T, et al. Effect of resistant starch on the gut microbiota and its metabolites in patients with coronary artery disease. J Atheroscler Thromb. 2018.","DOI":"10.5551\/jat.47415"},{"key":"6251_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jnutbio.2015.08.011","volume":"27","author":"C Haro","year":"2016","unstructured":"Haro C, Garcia-Carpintero S, Alcala-Diaz JF, Gomez-Delgado F, Delgado-Lista J, Perez-Martinez P, et al. The gut microbial community in metabolic syndrome patients is modified by diet. J Nutr Biochem. 2016;27:27\u201331.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"6251_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","volume":"65","author":"F Del Chierico","year":"2017","unstructured":"Del Chierico F, Nobili V, Vernocchi P, Russo A, Stefanis C, Gnani D, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65(2):451\u201364.","journal-title":"Hepatology."},{"issue":"5","key":"6251_CR37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/1758-2229.12079","volume":"5","author":"MS Kim","year":"2013","unstructured":"Kim MS, Hwang SS, Park EJ, Bae JW. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep. 2013;5(5):765\u201375.","journal-title":"Environ Microbiol Rep"},{"issue":"8","key":"6251_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134893","volume":"10","author":"B Di Luccia","year":"2015","unstructured":"Di Luccia B, Crescenzo R, Mazzoli A, Cigliano L, Venditti P, Walser JC, et al. Rescue of Fructose-Induced Metabolic Syndrome by antibiotics or Faecal transplantation in a rat model of obesity. PLoS One. 2015;10(8):e0134893.","journal-title":"PLoS One"},{"issue":"4","key":"6251_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175675","volume":"12","author":"UD Wankhade","year":"2017","unstructured":"Wankhade UD, Zhong Y, Kang P, Alfaro M, Chintapalli SV, Thakali KM, et al. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. PLoS One. 2017;12(4):e0175675.","journal-title":"PLoS One"},{"issue":"5","key":"6251_CR40","first-page":"1031","volume":"27","author":"L Javadi","year":"2018","unstructured":"Javadi L, Khoshbaten M, Safaiyan A, Ghavami M, Abbasi MM, Gargari BP. Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Asia Pac J Clin Nutr. 2018;27(5):1031\u20139.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"6251_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1017\/S0007114512003807","volume":"109","author":"K Gilbert","year":"2013","unstructured":"Gilbert K, Arseneault-Breard J, Flores Monaco F, Beaudoin A, Bah TM, Tompkins TA, et al. Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion. Br J Nutr. 2013;109(1):50\u20136.","journal-title":"Br J Nutr"},{"issue":"Suppl 1","key":"6251_CR42","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6251_CR43","first-page":"9390786","volume":"2018","author":"Y Liang","year":"2018","unstructured":"Liang Y, Zhang Y, Deng Y, Liang S, He Y, Chen Y, et al. Chaihu-Shugan-san decoction modulates intestinal microbe Dysbiosis and alleviates chronic metabolic inflammation in NAFLD rats via the NLRP3 Inflammasome pathway. Evidence-based complementary and alternative medicine : eCAM. 2018;2018:9390786.","journal-title":"Evidence-based complementary and alternative medicine : eCAM"},{"key":"6251_CR44","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3389\/fmicb.2017.02146","volume":"8","author":"M Lyu","year":"2017","unstructured":"Lyu M, Wang YF, Fan GW, Wang XY, Xu SY, Zhu Y. Balancing herbal medicine and functional food for prevention and treatment of Cardiometabolic diseases through modulating gut microbiota. Front Microbiol. 2017;8:2146.","journal-title":"Front Microbiol"},{"issue":"5","key":"6251_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2017.17033","volume":"28","author":"C Ozkul","year":"2017","unstructured":"Ozkul C, Yalinay M, Karakan T, Yilmaz G. Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2017;28(5):361\u20139.","journal-title":"The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology"},{"issue":"1","key":"6251_CR46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology."},{"issue":"1","key":"6251_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, et al. Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70\u201385.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"6251_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1.","journal-title":"Nucleic Acids Res"},{"key":"6251_CR49","doi-asserted-by":"crossref","unstructured":"Rognes T, Flouri T, Nichols B, Quince C, Mah\u00e9 F. VSEARCH: a versatile open source tool for metagenomics. Peerj. 2016;4(10).","DOI":"10.7717\/peerj.2584"},{"key":"6251_CR50","doi-asserted-by":"crossref","unstructured":"Alloui T, Boussebough I, Chaoui A, Nouar AZ, Chettah MC. Usearch: A Meta Search Engine based on a New Result Merging Strategy: International Joint Conference on Knowledge Discovery; 2016.","DOI":"10.5220\/0005642905310536"},{"key":"6251_CR51","unstructured":"Josse J, Sardy S, Wager S. denoiseR: A Package for Low Rank Matrix Estimation. 2016."},{"issue":"21","key":"6251_CR52","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","volume":"30","author":"DH Parks","year":"2014","unstructured":"Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics (Oxford, England). 2014;30(21):3123\u20134.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"6251_CR53","volume-title":"Garrett WS, et al","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L. Garrett WS, et al. Genome Biology: Metagenomic biomarker discovery and explanation; 2011."}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-019-6251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12864-019-6251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-019-6251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:46:10Z","timestamp":1722033970000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-019-6251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6251"],"URL":"https:\/\/doi.org\/10.1186\/s12864-019-6251-7","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"12 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Conjoint Health Research Ethics Board of Peking University People\u2019s Hospital (No. 2018PHB033\u201301) and written informed consent forms were obtained from all the participants. The study was carefully conducted complying with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"862"}}